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Abstract: Camelthorn, Alhagi maurorum Boiss, family Fabaceae has long been used in African folk
medicine owing to its richness in pharmacologically active metabolites. The crude extract (CEAM),
ethyl acetate fraction (EFAM) and n-butanol (BFAM) fraction of A. maurorum aerial parts were investigated for their total polyphenols and oral antiulcer activity using in-vitro and in-vivo models. The
major phenolic compound was isolated from the polyphenol-rich EFAM fraction and identified by
conventional and spectroscopic methods of analysis as isorhamnetin-3-O-rutinoside. Furthermore,
standardization of EAFM using UPLC-PDA-UV quantified isorhamnetin-3-O-rutinoside as 262.91
0.57 g/mg of the fraction. Analysis of EFAM using UPLC-PDA-MS/MS revealed tentative identification of 25 polyphenolic compounds. EFAM exhibited the most potent free radical scavenging
activity against DPPH, with an IC50 (27.73 ± 1.85 µg/mL) and an FRAP value of (176.60 ± 5.21 µM
Trolox equivalent (TE)/mg fraction) in comparison with CEAM and BFAM. Acetic acid-induced oral
ulcers in a rat model were used to evaluate the healing properties of A. maurorum aerial parts. EFAM
significantly decreased tumor necrosis factor-alpha (TNF-α) and interleukin-2 (IL-2) by 36.4% and
50.8%, respectively, in the ulcer tissues while, CEAM and BFAM exhibited lower activity at the same
dose. In addition, EFAM led to a significant (p < 0.0001) rise in the expression of proliferating cell
nuclear antigen (PCNA), a cell proliferation marker. A. maurorum exhibited a potent healing effect in
acetic acid-induced oral ulcers in rats by mitigating the release of pro-inflammatory cytokines and
improving PCNA expression.
Keywords: Alhagi maurorum; polyphenols; LC-MS-MS; antioxidant; oral ulcer; anti-inflammatory
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1. Introduction

distributed under the terms and

Oral mucosal ulcers are painful shallow sores or open lesions affecting the epithelium
or the underlying connective tissues of the oral mucosa [1]. Many factors contribute
to the development of oral ulcers including trauma, burns, bacterial or viral infection,
drug-induced side effects or allergic reaction, stress, recurrent aphthous ulcers, Behçet’s
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syndrome, and oral lichen planus [1]. The buccal mucosa is the most commonly affected
area of the oral cavity, followed by the tongue, and finally the lower lip. Due to the
recurrent stimulation of the tissues, these lesions can persist for weeks, especially for
tongue ulcers. Oral ulcers can be classified as acute or chronic ulcers based on their
appearance and progression. Ulcers lasting longer than 14 days are classified as chronic [2].
Oxidative stress is strongly associated with oral ulcer progression [3]. Reactive oxygen
species (ROS) are incorporated in many oral conditions [4]. Plant polyphenols possess a
potent therapeutic antioxidant effect protecting tissues against oxidative damage. They
suppress ROS formation by inhibiting oxidative-related enzymes, scavenging ROS, or
upregulating the antioxidant defense mechanisms. They modulate the inflammatory
process by interacting with ROS and terminating chain reactions even before affecting
cell viability [5]. Polyphenols can promote the ulcer healing process by reducing proinflammatory cytokines implicated in acute inflammation, down-regulating the cellular
and intercellular adhesion agents, and blocking both leukocyte-endothelium contact and
inflammatory process nuclear signaling pathways [6]. Polyphenols have been found to
reduce inflammation and improve the recovery process of chemically induced ulcers on rat
tongues [7].
Another study found that using polyphenols improved wound healing in oral sores
and periodontitis [8]. Wound healing occurs following disruption or damage to the normal anatomical structure and function and depends on the power of tissue regeneration,
resulting in a coordinated series of cellular and molecular processes including hemostasis,
inflammation, proliferative phase, angiogenesis, wound contracture, epithelialization, and
matrix remodeling [9].These processes depend on homogenous functions of neutrophils,
macrophages, fibroblasts, and endothelial cells that are controlled by the interaction with
other cells, extracellular matrix proteins, and growth factors. Any change in these processes
will lead to abnormal healing processes affecting successful wound healing [10]. Any drug
which interferes with the formation of clots, inflammatory reactions, or cell proliferation
can be used in the treatment of ulcers. The most widely consumed agents in treating
oral ulcers are corticosteroids and antibiotics; however, their use may be limited owing
to potential complications [11,12] Local anti-inflammatory drugs and painkillers are the
first lines of treatment for patients with oral ulcers; however, long-term use may result
in serious complications such as secondary fungal infections and drug resistance [13]. It
has been reported that the use of natural remedies in treating oral sores can result in an
improved recovery rate with minimal adverse effects [14].These findings encourage scientists to search for new effective, cheap, and safe remedies from nature for the treatment of
oral ulcers.
Alhagi maurorum Boiss (Camelthorn) is a widely distributed folk medicinal plant that
belongs to the family Fabaceae. It is a perennial, spiny, densely branched shrub, with
deep roots that can extend 15 m into the ground. The plant quickly colonizes an area
by producing new plants owing to its creeping roots [15]. Traditionally, the plant roots,
aerial parts, and manna are used to cure different diseases in different areas especially
in the MENA and Central Asian countries. In Egypt and Afghanistan, A. maurorum is
used to treat gastrointestinal, liver, and urinary tract disorders [15]. It is traditionally
recommended for treatment of progressive ulcers, hemorrhoids, cough, rheumatic pain,
angina, eczema, and gastritis in Pakistan, Uzbekistan, and Saudi Arabia [16].The manna of
Alhagi is reported in the Islamic traditional medicine (ITM) books for its laxative, detergent,
and antipyretic properties, and as a cure for cough and liver bile diseases [16]. The crude
extract of A. maurorum aerial parts exhibited a protective effect against peptic ulcers and
gastroesophageal reflux in rats [17]. Another study reported antiulcerogenic activity of
A. maurorum in treating gastric ulcers [15]. Pourahmad et al. [11] revealed that A. maurorum
steam distillate was effective in treating recurrent aphthous ulcers. In light of the cited
studies, nothing could be found in the literature exploring the metabolic profile of the
A. maurorum aerial parts responsible for its healing potential in oral ulcers or examining
the related healing mechanisms. Thus, the present study aimed at the standardization and
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profiling the polyphenol-rich fraction ethyl acetate (EFAM) of A. maurorum aerial parts
by adopting the UPLC-PDA and UPLC-PDA-ESI-MS/MS techniques. In addition, the
evaluation of the antioxidant activity of A. maurorum crude extract (CEAM) and its fractions,
namely, ethyl acetate (EFAM), and n-butanol (BFAM), were evaluated by DPPH and FRAP
assays. Furthermore, the antiulcerogenic activity of A. maurorum aerial parts extract and
fractions was evaluated in vivo on chemically induced tongue ulcers in rats.
2. Results
2.1. Extraction and Fractionation of A. maurorum
One of the main goals of this study is to prepare a standardized polyphenol-rich fraction from the aqueous alcohol extract of the aerial parts of A. maurorum. This incorporates
extraction, fractionation and standardization. The aqueous alcohol extract CEAM was
fractionated using increasing the polarity solvents n-hexane, ethyl acetate, and n-butanol.
To obtain fractions with a high concentration of polyphenols, the n-hexane fraction was
prepared first as a step in the purification and extraction of relatively nonpolar components,
followed by the preparation of the ethyl acetate (EFAM) and n-butanol (BFAM) fractions.
2.2. Determination of Total Polyphenolic and Flavonoid Content of A. maurorum
The spectrophotometric assays of the total polyphenolic and flavonoid content revealed that the highest polyphenol and flavonoid content was found in EFAM, followed by
CEAM and BFAM (Table 1).
Table 1. Total phenolic content (TPC as mg GAE/g dry extract) and total flavonoid content (TFC as
mg RE/g dry extract) of different fractions of A. maurorum.
Total Phenolic Content
(mg GAE/g Dry Extract)

Total Flavonoid Content
(mg RE/g Dry Extract)

CEAM

36.50 ± 2.2

22.90 ± 1.07

EFAM

53.19 ± 4.2

47.96 ± 3.1

BFAM

11.81 ± 0.36

4.21 ± 0.4

Data are expressed as mean ± SD, (n = 3).

2.3. Identification of the Major Polyphenol Compound of EFAM
Phytochemical investigation of the EFAM led to the isolation and identification of the
major flavonoid compound, isolated as a yellow powder (12.8 mg): 1 H NMR data (400 MHz,
DMSO-d6): aglycone: δH 3.83 (3H), 6.17 (d, J = 2.0 Hz, 1 H, H-6), 6.46 (d, J = 2.0 Hz, 1 H)
6.38 (1H, d, J = 2.0 Hz, H-8),7.85 (1H, d, J = 2 Hz, H-20 ), 6.91 (1H, d, J = 8.4 Hz, H-50 ), 7.51
(1H, dd, J = 8.4, 2.0 Hz, H-60 ); sugar moiety: δH 1.02 (3H, d, J=6.2 Hz, H-600 rham), 3.12-3.86
(10 H, m, other sugar protons), 4.57 d (1.4) 4.42 (1H, br. s, H-1”rham), and 5.41 (1H, d,
J = 8.5 Hz, H-100 glc). 13 C NMR data (100 MHz, DMSO-d6) 156.93 (C-2), 133.70 (C-3), 177.71
(C-4), 163.05 161.58 (C-5), 99.8 (C-6), 165.35 (C-7), 94.41 (C-8), 156.8 (C-9), 104.00 (C-10),
121.49 (C-10 ), 115.61 (C-20 ), 149.98 (C-30 ), 147.41 (C-40 ), 113.5 (C-50 ), 122.7 (C-60 ), 104.61
(C-100 ), 74.16(C-200 ), 77.12 (C-300 ), 70.6(C-400 ), 76.42 (C-500 ), 67.37 (C-600 ), 101.59 (C-1000 ), 70.7
(C-2000 ), 70.5 (C-3000 ), 71.8 (C-4000 ), 68.6 (C-5000 ), 17.9 (C-6000 ), 56.2 (O-Me). Accordingly, it was
proposed to be isorhamnetin-3-O-β- rutinoside[18]. This compound was used as standard
reference for the standardization of EFAM.
2.4. Standardization of EFAM Using Ultra Performance Liquid Chromatography (UPLC) Analysis
The PDA chromatogram of EFAM was recorded at 270 nm (Figure 1a) and showed
a major peak (44.54%) at Rt = 21.7 min, corresponding to isorhamnetin-3-O-rutinoside.
A calibration curve of the isolated isorhamnetin-3-O-rutinoside was established on the
same UPLC device with the same conditions and parameters (Figure 1b). The calibration
curve equation was found to be Y = 0.02416X − 0.7226, and the correlation coefficient
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2.5. Characterization of EFAM Polyphenols by LC-MS/MS
This is the first time that the polyphenolic profile of EFAM has been reported utilizing UPLC-PDA-ESI-MS/MS (Table 2). Twenty-five compounds were tentatively identified, including phenolic acids and their derivatives (four compounds). The rest of the compounds were flavonoids and their derivatives.
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2.5. Characterization of EFAM Polyphenols by LC-MS/MS
This is the first time that the polyphenolic profile of EFAM has been reported utilizing
UPLC-PDA-ESI-MS/MS (Table 2). Twenty-five compounds were tentatively identified, including phenolic acids and their derivatives (four compounds). The rest of the compounds
were flavonoids and their derivatives.
Table 2. Peak assignment of the metabolites detected in the ethyl acetate fraction of A. maurorum
using UPLC-PDA-ESI-MS/MS (negative mode).
Rt
(Min)

1

2.5

Caffeic acid

—

179

2

3.5

Sinapic acid hexoside

228

385.0

3

3.97

Caffeoyl-hexose-deoxyhexoside

318

487.0

4

4.5

Chrysoeriolpentoside
(chrysoeriol-7-O-xylosoid)

220, 335

5

7.85

Dihydroxybiflavone derivative

6

17.5

Caffeoyl-hexose-deoxyhexoside

7

20.25

Quercetin hexoside
(Quercetin3-O-β-D-glucoside)

221, 330

463

8

21.9

Kampferol hexoside
(Kampferol-3-O-β-D-glucoside)

220, 330

9

22.12

Quercetin diglucoside
(Quercetin-3-O-di-glucoside)

10

22.77

11

Identified Compound

UV-Vis
(λmax)

[M − H]−
(m/z)

Peak #

Fragment Ions
(m/z)

Percentage (%)

Occurrence

Reference

135

0.2

A. maurorum

[19]

223, 179

0.65

A. maurorum

[19]

308,179

6.40

-

[20]

431.1

299

0.21

A. maurorum

[15]

220, 332

521.01

375, 331

0.15

-

[21]

320

487.0

308, 179

0.70

-

[20]

301, 179

1.56

A. maurorum
A. maurorum

[22–24]

447.02

285, 284

2.15

A. maurorum
A. sparsifolia

[24–26]

257, 335

625.3

271, 301,179

1.75

A. maurorum

[27]

Quercetin rhamnoside
(quercetin-3-O-β- rhamnoside)

225, 332

447.23

301,179

3.85

A. maurorum
A. persarum

[22–24]

23.7

(Iso)rhamnetin rhamnoside

235, 335

461

315

0.99

-

[28]

12

24.58

Isorhamnetin-3-Orhamnopyranosyl hexoside
(Isorhamnetin-3-O-β-rutinoside)

250, 342

623.12

315, 301, 179,
151

5.35

A. maurorum
A. maurorum

[18,24,28]

13

26.5

(Iso)rhamnetindirhamnopyranosyl- hexoside
Isorhamnetin-3-O-rhamnosylrutinoside (Typhaneoside)

230, 330

769.18

454, 315

0.63

A. maurorum

[18,29]

14

29.2

(Iso)rhamnetin
3-O-hexosyl-neo-hesperidoside
(Isorhamnetin
3-O-glucosylneo-hesperidoside)

250, 350

803.21

623, 477, 315

0.75

A. maurorum

[15]

15

32.5

Isorhamnetin-3-Orhamnopyranosyl hexoside
(Isorhamnetin-3-O-β-rutinoside)

268, 342

623.21

315, 301, 179,
151

0.88

A. maurorum
A. maurorum

[18,24,28]

16

34.47

Apigenin-rhamnosyl-hexoside
(Apigenin-8-C-rhamnosyl-6-Cglucoside)

272, 373

577.3

503, 473, 383,
353

2.98

-

[30]

17

35.0

Kaempferol-3-O-rutinoside

262, 362

593.17

285, 284

0.42

A. maurorum

[28,31]

18

35.5

(Iso)rhamnetinhexoside
(Isorhamnetin-3O-β-D-glucopyranoside)

268, 342

477.2

315

0.48

A. saparsifolia

[26]

19

36.12

30 -O-methylorobol

283,357

299.12

284, 271

0.58

A. maurorum

[23,32]
[18,26,28]

20

36.8

Quercetin

254, 374

301.08

179, 151

0.83

A. maurorum
A. saparsifolia

21

37.0

Kaempferol

222, 335

285.9

239, 187

0.85

A. maurorum
A. saparsifolia

[18,26,33]

22

37.80

Quercetin hexoside
(Quercetin-3-O-β-Dglucopyranoside)

221, 330

463

301, 179

2.35

A. maurorum
A. maurorum

[22–24]

23

38.98

Dihydroxy methoxy
diprenyl isoflavone
(5,7-dihydroxy-40 -methoxy-6,
8-dipenylisoflavone)

225, 335

419.08

404, 361

4.50

-

[34]

24

39.33

Isorhamnetin

224, 338

315.2

301, 272

2.75

A. maurorum

[18,29]

25

40.5

Tamarixetin

220, 331

315

300, 151

3.12

A. maurorum

[35,36]
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Compound 1 showed a molecular ion peak at m/z 179 and a base peak in the MS/MS
spectrum negative mode at m/z 135, corresponding to [M − H–CO2 − ]− , which was in
agreement with the reported data on caffeic acid [19]. Compound 2 was identified as sinapic
acid hexoside, with an [M − H]− at m/z 385 and a base peak at m/z 223 [M − H–162]− ,
attributed to the loss of a hexosyl radical [19]. Compounds 3 and 6 were identified as
caffeoyl-hexose-deoxyhexoside based on the [M − H]− at m/z 487.0 and the fragment ion
peak detected at m/z 308 by the expulsion of caffeic acid moiety at m/z 179 due to the loss
of deoxyhexose and hexose moieties [20]. Compound 4 showed an [M − H]− ion peak
at m/z 431.1 with the fragment ion at m/z 299 owing to the loss of a pentoside moiety.
This compound was identified as chrysoeriol pentoside [15]. Compound 5 exhibited a
molecular ion peak at m/z 521.0. It yielded an anion at m/z 375 owing to the base peak and
another fragment ion peak at m/z 331, indicating the breaking down and withdrawal of
CO2 in the MS2 spectrum; the peak abundance of both ions was similar to that of biflavones
in specific [21]. Thus, it could be potentially identified as a dihydroxy-amento flavone.
Compounds 7 and 22 were suggested to be quercetin 3-O-β-D-glucoside based on the
molecular ion peak at m/z 463. In the MS2 spectrum, an aglycone ion fragment peak at m/z
301 [M − H–162]− was detected due to the removal of a hexosyl radical [22]. Compound 8
showed a major peak of [M − H]− at m/z 447. Two ion fragments were distinguished in
the MS2 spectrum, including a peak at m/z 285 (-162 Da) and a peak at m/z 284 (-163 Da)
representing kaempferol aglycone, which was confirmed by the characteristic fragmentation
pattern with an intense peak at m/z 151. The loss of 162 Da moiety revealed the presence
of a hexoside moiety. The intensity of [M − H–162]− at m/z 285 was characteristic of
3-O-glycosylation. The mass spectrum tentatively established compound 8 as kaempferol
3-O-β-D-glucoside [25]. Compound 9 showed a base peak at m/z 625.3 [M − H]− and
fragments at m/z 463 and 301, which indicated the sequential loss of hexosyl radicals,
suggesting its identification as quercetin-3-O-diglucoside [27]. Compound 10 produced
a precursor ion peak [M − H]− at m/z 447.23 which produced a [M − H–146]− ion at
m/z 301, attributed to the cleavage of rhamnosyl radical. Thus, it was suggested to be
quercetin-3-O-rhamnoside [22]. Similarly, compound 11 was referred to isorhamnetin3-O-rhamnoside [28]. Compounds 12 and 15 showed a base peak at m/z 623.12 and a
fragment ion peak at m/z 315, indicating that the aglycone (iso)rhamentin was left after the
removal of the rutinose group (308 Da) as a base peak, indicating a (1–6) interglycosidic
linkage [18]. Compound 13 showed a molecular ion peak [M − H]− at m/z 769.18. A parent
ion peak was produced [M − H]− at m/z 454 owing to the removal of two rhamnose and
hexose units and a fragment ion peak at m/z 315, indicating the presence of the aglycone
isorhamentin; thus, it was identified as isorhamnetin-dirhamnopyranosyl-hexoside [18].
Compound 14 produced a deprotonated molecule at m/z 803.21 in which the fragmentation
pattern showed ion peaks at m/z 477 because of isorhamnetin glucoside, which was
further fragmented to the aglycone isorhamnetin product ion at m/z 315 by losing a
glucose moiety. Moreover, the other characteristic fragment was m/z 623, corresponding
to isorhamnetin-3-O-neohesperidoside; this was identified as isorhamnetin-3-O-glucosylneo-hesperidoside [15]. Compound 16 showed a base peak at m/z 577.3. The way these
fragments were formed was identical to a di C-glycosyl flavone. It produced fragment
ion peaks at m/z 503 [M − H–74]− and m/z 473 due to [(M − H)–104]− , which are the
characteristic peaks of a C-linked rhamonsyl. Other fragment ions at m/z 383 [M − H–
90]− and m/z 353 [M − H–120]− were characteristic of a C-linked glucosyl. The intensity
of the fragment ion peak produced from the carbon-linked glucosyl radical was higher
than that produced from the carbon-linked rhamnosyl, which confirmed that the glucose
moiety was fixed to the carbon at the sixth position and the rhamnose moiety was at the
eighth position; therefore, the compound was referred to as apigenin-8-C-rhamnosyl-6C-glucoside [30]. Furthermore, compound 17 showed an [M − H]− peak at m/z 593.17
and a base peak at m/z 285 [M − H–308]− owing to the loss of a rutinose moiety, and
was suggested to be kaempferol-3-O-rutinoside [28]. Compound 18 was identified as
isorhamnetin-3-O-glucoside, with a molecular ion peak at m/z 477.2 [M − H]− and a base
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peak at m/z 315, attributed to the aglycone (iso)rhamnetin product after losing a hexosyl
group (162 Da) [26]. Compound 19 was identified as 30 -O-methylorobol, with a [M − H]−
ion at m/z 299.12 and a base peak at m/z 284 [M − H–15]− corresponding to losing a methyl
radical [19]. The data on compounds 20 and 21 were in agreement with the reported data
on the characteristic fragmentation pattern of quercetin and kaempferol aglycones [28,33].
Compound 23 was proposed to be 5,7-dihydroxy-40 -methoxy-6, 8-diprenylisoflavone, as it
showed an [M − H]− ion peak at m/z 419.08 together with fragment ion peaks at m/z 404
[M − H–15]− and m/z 361 [M − H–15–43]− owing to the sequential removal of methyl and
an isopropyl radical [34]. Compound 24, with [M − H]− at m/z 315.2 and fragment ions at
m/z 301 and 272, was referred to as (iso)rhamnetin aglycone [18].Compound 25 showed an
[M − H]− peak at m/z 315 and a base peak at m/z 300 [M − H–15]− , owing to the typical
demethylation of tamarixetin [35].
2.6. In Vitro Assay
2.6.1. DPPH Assay
The DPPH assay results (Table 3) showed that the EFAM exhibited the most potent antioxidant effect in comparison with the CEAM and BFAM, with IC50 (27.73 ± 1.85 µg/mL).
The EFAM results were comparable to Trolox, the positive control.
Table 3. Antioxidant activity of the different fractions of A. maurorum using DPPH and FRAP assays.
DPPH IC50 (µg/mL)

FRAP (µM TE/mg Extract)

CEAM

45.22 ± 2.11

139.90 ± 4.01

EFAM

27.73 ± 1.85

176.60 ± 5.21

BFAM

52.48 ± 35.85

78.04 ± 7.92

Trolox

22.35 ± 0.87

-

Data are expressed as mean ± SD, (n = 3). Trolox was used as the positive control.

2.6.2. FRAP Assay
The FRAP assay results (Table 3) revealed that the EFAM showed the most potent
antioxidant effect (176.60 ± 5.21 µM Trolox equivalent (TE)/mg fraction), followed by the
CEAM and BFAM.
2.6.3. Evaluation of the Cytotoxic Activity of the Different Fractions of A. maurorum
(MTT Assay)
Before assessing the antiulcer activity of the CEAM, EFAM, and BFAM, their cytotoxicity
against the OEC cell line was evaluated by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium
bromide (MTT) assay. For 24 h, OEC was subjected to CEAM, EFAM, and BFAM. Only the
EFAM and CEAM exhibited statistically significant cytotoxic effects after 24 h at doses of
0.5 mg/mL or higher. According to these findings, EFAM, BFAM, and CEAM exhibited no
effect on cell viability at concentrations equal to or greater than 0.5 mg/mL. On the other
hand, EFAM induced cell proliferation starting from the treated concentration (0.5 mg/mL),
leading to a 5.56 ± 2.52% increase in cell proliferation (p < 0.05) (Figure 2).
2.7. In Vivo Assay
2.7.1. Histopathological Examination
The lingual mucosa in the control group showed normal histomorphological structure
over 14 days (Figure 3A–C); however, the lingual mucosa in the vehicle-treated group
showed minimal regeneration, as represented by the large focal necrotic and ulcerative
lesions in the covering mucosa (black arrow) (Figure 3D). These features were accompanied
by many constricted and dilated blood vessels (red star) and submucosal/intermuscular
mononuclear and polymorphonuclear inflammatory cell infiltrates (black star) (Figure 3E,F).
Upon treating the tissues with the CEAM, an apparent intact covering epithelium with

The FRAP assay results (Table 3) revealed that the EFAM showed the most potent
antioxidant effect (176.60 ± 5.21 μM Trolox equivalent (TE)/mg fraction), followed by the
CEAM and BFAM.
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The EFAM markedly improved ulcer healing during the treatment period and helped
to form a complete and thickened squamous epithelium with keratin layer (arrow); occasional mild congestion of submucosal blood vessels was observed (red star) (Figure 3K).
On day 14, an apparently intact and more keratinized covering epithelium (arrow)
9 of 20
with mild focal submucosal inflammatory cells (black star) showed minimal abnormal alterations among the different groups (Figure 3L).

Figure 3. Photomicrographs of tongue sections stained with H and E (100×). Negative control rats
Figure 3. Photomicrographs of tongue sections stained with H and E (100×). Negative control rats
(A,B,C), vehicle (D,E,F), CEAM (G,H,I), EFAM (J,K,L), BFAM (M,N,O) on days 3, 7 and 14, re(A–C),
vehicle (D–F), CEAM (G–I), EFAM (J–L), BFAM (M–O) on days 3, 7 and 14, respectively.
spectively.

2.7.2. Inflammatory Markers
Table 4 shows the effect of A. maurorum on the level of TNF-α in tongue tissues in the
experimental group of rats. Inducing ulcers using acetic acid caused the TNF-α level to
increase significantly, by 155% at p < 0.0001 in comparison with the control group, indicating
that the animal models were reproduced successfully. The administration of EFAM, CEAM,
and BFAM showed that TNF-α levels were significantly decreased, by 36.4%, 28.9%, and
28.6%, respectively, in comparison with the vehicle-treated group (Figure 4).
Table 4. Effect of the A. maurorum extract (CEAM), ethyl acetate (EFAM), and butanol (BFAM)
fractions on tongue TNF-α and IL-2 levels in acetic acid-induced tongue ulcers in rats.
Group

TNF-α
(pg/mL Protein)

IL-2
(pg/mL Protein)

Control

136.64 * ± 8.37

67.63 * ± 8.64

Vehicle

211.79 ± 11.69

138.33 ± 8.87

CEAM

150.65 *,# ± 8.08

79.87 * ± 9.84

EFAM

134.62 * ± 9.08

68.07 * ± 6.22

BFAM

151.16 *,# ± 7.47

80.02 *,# ± 4.12

Data are presented as the mean ± SD (n = 6). * or #: Significantly different from the vehicle or ethyl acetate fraction
group at p < 0.05 using One-way ANOVA followed by Tukey–Kramer as a post hoc test.
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Figure 4. Effect of the A. maurorum extract and fractions on tongue tissue TNF-α level in acetic
acid-induced tongue ulcers in rats compared with the vehicle and control rats. * p < 0.0001 vs. vehicle
group and # p < 0.05 vs. EFAM group, using One-way ANOVA followed by Tukey–Kramer as a post
hoc test. Results are shown as mean ± SD (n = 6).

The effect on IL-2 levels was similar to that on TNF-α, as they were increased two-fold
at
p
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11 of 20
ing effect of the ulcerative acetic acid was ameliorated by the administration of EFAM,
CEAM, and BFAM, which reduced IL-2 levels by 50.8%, 42.3%, and 42.2%, respectively, in
comparison with the vehicle-treated group (Figure 5).
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6A). In addition, there was a significant rise between the vehicle and EFAM groups on the
day (12.6 ± 1.9 and 21 ± 1.1; p < 0.0001) (Figure 6B). In the EFAM group, there was a
14th day (12.6 ± 1.9 and 21 ± 1.1; p < 0.0001) (Figure 6B). In the EFAM group, there was a
significant rise in the area of positively-stained PCNA cells on day 14 when compared with
significant rise in the area of positively-stained PCNA cells on day 14 when compared
the same respective group on day three (19.6 ± 0.6 and 21 ± 1.1; p < 0.05). These results
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demonstrated that there was an increase in the proliferation of cells in the healing regions
of the lingual mucosa in EFAM topically-treated rats.
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ulcers; this reaction was localized on the epithelium owing to re-epithelialization and restoration of the tongue mucosa. Microscopical examination of PCNA immunohistochemistry revealed a faint brown stain in the vehicle-only treated group, while positive brown
staining was highly expressed in the EFAM group over the 14 days of treatment (Figure
6A). In addition, there was a significant rise between the vehicle and EFAM groups on the
of 20a
14th day (12.6 ± 1.9 and 21 ± 1.1; p < 0.0001) (Figure 6B). In the EFAM group, there11was
significant rise in the area of positively-stained PCNA cells on day 14 when compared
with the same respective group on day three (19.6 ± 0.6 and 21 ± 1.1; p < 0.05). These results
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thatthere
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C):
Normal
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were
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(magnification, ×400, the scale bar indicates 50 µ). (A–C): Normal rats were treated with the vehicle
only on days 3, 7, and 14, respectively. (D–F): Acetic acid-induced tongue ulcer rats treated with
vehicle only on days 3, 7, and 14, respectively. (G–I): Acetic acid-induced tongue ulcer rats treated
with EFAM on days 3, 7, and 14, respectively. The brown precipitate represents positively-stained
PCNA. (b) Amount of positively immunostained PCNA, expressed as the mean area percentage
(mean%), in the control, vehicle, and EFAM groups on 3, 7, and 14 days. * p < 0.0001 vs. control group
of the same time interval, and # p < 0.0001 vs. vehicle group at the same time interval, ¥ p < 0.05,
¥¥ p < 0.0001 vs. respective group on day 3 and † p < 0.05 vs. respective group on day 7 using two-way
ANOVA followed by Bonferroni as a post hoc test. Results shown as mean ± SD (n = 6).

3. Discussion
Many natural secondary metabolites demonstrated various biological effects [37–41],
including antioxidant potential via their ROS scavenging abilities [39,42,43]. The high
antioxidant activity of polyphenols in oral mucosa is most likely responsible for their ability
to protect tissues against periodontal and dental diseases, as polyphenols come into contact
with oral tissues before being absorbed or digested [44,45]. Polyphenols reach the highest
concentration on oral mucosa in comparison with all other tissues of the gastrointestinal
tract [38]. Plant polyphenols and flavonoids also demonstrated anti-inflammatory properties in both in vitro and in vivo models [43,46,47]. These anti-inflammatory activities can
be achieved through scavenging free radicals, regulating cellular activities in inflammatory
cells, and modulating the activity of inflammatory enzymes such as phospholipase A2,
COX, and NOS, as well as through modulating the expression of other proinflammatory
cytokines such as IL-1β and TNF-α [46,48,49].
EFAM was found to possess the highest total phenolic (53.19 mg GAE/g dry extract)
and flavonoid (47.96 mg RE/g dry extract) content, and showed both the most potent
radical scavenging capacity against DPPH (IC50 = 27.73 ± 1.85 µg/mL) and the highest
reducing power (a FRAP value of 176.60 ± 5.21 µM TE/mg extract). This encouraged
us to standardize and highlight the polyphenol profile of EFAM and compare its oral
antiulcer activity to those of BFAM and CEAM. The polyphenolic profile of EFAM was
reported for the first time using the UPLC/PDA/ESI/MS method. Twenty-five polyphenol
derivatives were tentatively identified. Most of the identified polyphenols in the EFAM
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were reported previously in A. maurorum, although caffeoyl-hexose-deoxyhexoside, dihydroxybiflavone derivative, (iso)rhamnetin rhamnoside, apigenin-rhamnosyl-hexoside, and
dihydroxy methoxy diphenyl isoflavone were identified in the current study for the first
time. Phytochemical investigation of EFAM resulted in the isolation and identification of
two major flavonoids, isorhamnetin-3-O-rutinoside and quercetin-3-O-rhamnoside, both of
which were previously reported in A. maurorum [18].
Accumulating evidence has shown that inflammatory reactions and reactive oxygen
species contribute to the etiology of oral ulcer lesions [50], and that inflammation results
in delayed wound healing. To achieve an effective antiulcer therapy, the inhibition of the
proinflammatory cycle can be targeted [51]. These findings explain the activity of plants
containing polyphenols in improving oral ulcers by reducing proinflammatory markers,
scavenging free radicals, and decreasing oxidative stress [50,52].
The current study is the first to report the efficacy of different fractions of A. maurorum
in healing tongue ulcers. Treatment with acetic acid resulted in severe histopathological
destruction (necrosis, skin lesions, and inflammation) as well as an increase in the levels of
the tongue tissue proinflammatory cytokines TNF-α and IL-2. Biochemical investigation
proved that the topical application of EFAM in the treatment group significantly decreased
inflammation, as demonstrated by the reduction in the levels of mucosal proinflammatory
TNF-α and IL-2 after days 3, 7, and 14, with a gradual decrease from one period to another.
This is in agreement with previous reports [53,54] finding that the improvement in healing
of induced oral ulcers in in vivo studies was associated with a decrease in mucosal levels
of proinflammatory cytokines. Pourahmad et al. [11] reported that A. maurorum as a
source of flavanones could inhibit macrophage activity in oral lesions and thereby inhibit
the expression of TNF-α and mediators of inflammation; this is in agreement with the
present study, as EFAM improved the healing of aphthous ulcers in comparison with the
vehicle-only treatment group.
These effects were further confirmed by histopathological investigation of the CEAM
and EFAM groups, which showed minimal damaging effects as represented in the gradual
reduction in inflammation, restoration of mucosal epithelium, and appearance of a keratin layer all occurring gradually over the 14 days of treatment. General improvement
in the pathological structure of the acetic acid induced-tongue ulcers was observed compared to the vehicle-only treated rats, which showed signs of epithelial atrophy, absence
of a keratin layer and the presence of inflammatory cells infiltration. The best healing
effect was found in the EFAM-treated group at the end of the 14-days treatment period.
Pourali and Yahyaei [55] studied the role of A. maurorum in enhancing wound healing
through tissue remodeling and collagen deposition, which is in agreement with the results of the present study. Ulcer healing is a complex programmed process that requires
epithelial cell migration and proliferation for continued re-epithelialization [56]. PCNA
shows a vital role in proliferating and repairing DNA in the cells. Treatment with EFAM
increased the number of PCNA-positive cells localized in the tongue mucosa. This indicates that one of the mechanisms of A. maurorum in accelerating ulcer healing is probably
through increased cell proliferation. Structural analysis of the flavonoids showed that
the double bond between carbon 2 and carbon 3, the hydroxyl groups at 5, 7, 30 , and
40 , and the position of ring B at carbon 2 strongly suppressed cytokine expression [57].
It was proven that isorhamnetin rutinoside could potentially inhibit expression of proinflammatory mediators (TNF-α and IL-6), explaining its anti-inflammatory activity [58].
Isorhamnetin rutinoside has been evaluated for its local anti-inflammatory property in
croton oil-induced rat ear edema, with a strong impact on TNF-α expression resulting in
83.3% reduction [59]. Moreover, many reports have proven that glycosylated flavonoids
are potent inhibitors of cytokine expression [60,61]. A recently isolated new isorhamnetin
glycoside derivative (isorhamnetin-3-O-[20 ,30 -O-isopropylidenea-L-rhamnopyranosyl] -(10 60 )-O-b-D-glucopyranoside) exhibited anti-inflammatory effect with potent inhibition of
the mRNA expression of IL-6 and TNF-α[58]. Quercetin-3-O-rhamnoside was reported
to inhibit the primary vascular response mediated by amines and prostaglandins, and
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produced a reduction of 47% in the level of myeloperoxidase activity on a mouse ear edema
model [62]. In Salaverry et al. [63] it was shown that aqueous extract of Smilax campestris
with quercetin-3-O-rhamnoside as the main component significantly reduced production of
pro-inflammatory cytokines along with tumor necrosis factor (TNF)-α, interleukin (IL)-1β,
IL-6, IL-8 and monocyte chemoattractant protein (MCP)-1, and reduced the activity of
metalloproteinase (MMP)-9 in lipopolysaccharide-activated macrophages as well as.
4. Materials and Methods
4.1. Materials
The aerial parts of A. maurorum Boiss, F. Leguminosae were obtained from Aswan,
Egypt. Authentication was achieved by Therese Labib, Consultant at El-Orman Botanic Garden, Giza, Egypt. A voucher specimen was deposited at the herbarium (PHG-P-AM-243)
at the Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Egypt.
All solvents were of analytical grade, while those used in the preparative HPLC and
UPLC/PDA/ESI/MS assays were of HPLC grade. Rutin, gallic acid, and Trolox were
obtained from Sigma-Aldrich (Schnelldorf, Germany). ELISA kits, including TNF-α kit
Catalogue No. CSB-E1252r, were purchased from Cusabio (Huston, TX, USA), and the IL-2
kit Catalogue No. E-EL-R0027 was purchased from Elabscience (Huston, TX, USA).
4.2. Plant Extraction and Fractionation of A. maurorum
Air-dried powdered aerial parts of A. maurorum (1 kg) were thoroughly extracted by
maceration with 70% ethanol (1 L × 3) for 48 h at room temperature followed by filtration.
The extracts were dried at 45 ◦ C using a rotary vacuum evaporator, yielding 95 g (9.5%).
For further analysis, 15 g of the dried hydro-alcohol extract was labeled as CEAM and
freeze-dried. The remaining dried extract was dissolved in 400 mL of distilled water. The
aqueous solution was fractionated using increasing polarity solvents such as n-hexane,
ethyl acetate, and n-butanol. The dried fractions yielded 20, 18, and 23 g, respectively.
The CEAM (15 g), EFAM (18 g), and BFAM (23 g) were freeze-dried for phytochemical
and biological investigation. The CEAM, EFAM, and BFAM were subjected to further
investigation, while the n-hexane fraction was prepared as a first step in purification in
order to extract the nonpolar compounds not belonging to the class of polyphenols.
4.3. Determination of Total Polyphenolic and Flavonoid Content of A. maurorum
The total polyphenolic and flavonoid content of the CEAM, EFAM, and BFAM was
assayed using the micro-plate adapted Folin–Ciocalteu and aluminum chloride methods,
respectively, using Fluostar Omega microplate reader (BMG Labtech, Ortenberg, Germany) [64,65]. Gallic acid and rutin were employed as the standards to determine the
total polyphenolic content (mg GAE/g extract or fraction) and flavonoid content (mg
RE/g extract or fraction), respectively. For the calibration curve establishment, gallic acid
concentrations ranged from 7.8 to 500 g/mL, while rutin concentrations ranged from 10 to
1000 g/mL.
4.4. Isolation and Identification of the Major Polyphenolic Compound of EFAM
The isolation of the major compounds in the EFAM was carried out by High Performance Liquid Chromatography technique using a Waters 2695 Alliance HPLC system
with a Waters photodiode array detector equipped with preparative column (C18 Kromasil
1 cm × 250 mm, 5 µm) (Waters Corp., Milford, MA, USA). For system control and data acquisition, Empower 3.0 Software (Waters, Milford, MA, USA) was used. The sample solvent
was methanol with a concentration of 1 mg/mL; filtration using a 0.45 µm syringe filter was
then carried out. The mobile phase system consisted of two phases: (A) 0.1% formic acid in
water, and (B) 0.1% formic acid in methanol, with the following gradients: 0–3 min (10% B),
3–25 min (10–70% B), 25–30 min (70% B), 30–35 min (70–100% B), 35–40 min (100% B),
40–41 min (100–10% B), 41–46 min (10% B), monitored using PDA (190 to 800 nm). The flow
rate was 3 mL/min and the injection volume was 100 µL. The structures of the isolated
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compounds were elucidated by 1 H and 13 C NMR spectroscopical analyses conducted on
Bruker Avance III HD 400 MHz (Bruker AG, Fällanden Switzerland) [19].
4.5. Standardization of EFAM Using Ultra Performance Liquid Chromatography (UPLC) Analysis
The polyphenol-rich EFAM fraction was standardized. The experiment was carried out
on a Thermo Fisher UPLC Model Ultimate 3000 (Agilent, Santa Clara, CA, USA) equipped
with PDA–UV–Visible light detector, a Hypersil GOLD column (250 mm × 4.6 mm i.d.)
and particle size 5 µm. A calibration curve of the isolated main flavonoid isorhamnetin-3O-rutinoside was established with a concentration range of 100–1000 µg/mL; the EFAM
concentration was 1 mg/mL. All experiments were performed in three replicates [66].
4.6. UPLC/PDA/ESI/MS/MS Analysis of Polyphenol-Rich Fraction (EFAM)
The profiling of the chemical constituents was performed according to [67] using
mass spectrometric analysis carried out on a Waters™ ACQUITY Xevo™ TQD system
composed of an ACQUITY UPLC H-Class system and a XevoTMTQD triple-quadrupole
tandem mass spectrometer ESI (-ve mode) as the electrospray ionization (ESI) interface
(Waters Corp., Milford, MA, USA). The column used was a C18 100 mm × 2.1 mm column
(p.s., 1.7 µm) (Waters, Ireland). The sample solvent was methanol at a concentration of
1 mg/mL, and the sample was filtered using a 0.2 µm micropore filter. The mobile phase
system consisted of two phases: (A) 0.1% formic acid in water, and (B) 0.1% formic acid
in acetonitrile, with the following gradients: 0–4 min, 15% B; 4–8 min, 20% B; 8–30 min,
55% B; 30–35 min, 90% B; 35–40 min, 15% B, with a flow rate of 200 µL/min and the
injection volume adjusted at 10 µL. The scan range was 100–1000 m/z. The following
settings were applied to the instrument: capillary voltage 3.5 kV; detection at cone voltages
20 V–95 V; radio frequency (RF) lens voltage 2.5 V; source temperature 150 ◦ C; desolvation
gas temperature 500 ◦ C. Nitrogen was used as desolvation and cone gas at a flow rate of
1000 and 20 L/h, respectively. MassLynx 4.1 software (Waters, Milford, MA, USA) was
used to control system operation and for data collection.
4.7. In Vitro Studies
4.7.1. DPPH Assay
DPPH free radical assays of CEAM, EFAM, and BFAM were performed according to [68].
All assays were carried out in three replicates. Trolox was used as the positive control.
4.7.2. FRAP Assay
The antioxidant power of CEAM, EFAM, and BFAM was determined by FRAP assay
using a FluoStar® Omega microplate reader (BMG LABTECH, Ortenberg, Germany). Trolox
was employed as the standard, with concentrations ranging from 50 to 4000 µM to calculate
the antioxidant power presented as µM TE/mg extract or fraction [69].
4.7.3. Cytotoxic Activity (MTT Assay)
Oral epithelial cell OEC cell line was cultivated as adherent cultures on Petri dishes
and kept at 37 ◦ C, as reported by Picerno et al. [70]. The MTT reduction test was used to
assess cell viability according to Lopes et al. [71]. The cell viability findings are presented
as the mean ± SD of not less than four separate assays carried out in three replicates, and
are presented as the percentage of the untreated control cells.
4.8. In Vivo Traumatic Ulcer Healing Study
4.8.1. Animals
Adult male Sprague Dawley rats (150 and 200 g) were obtained from the Agricultural
Research Center, Giza, Egypt. The rats were housed in separate cages, three rats per cage
in the animal house facility of the Faculty of Pharmacy, Ain Shams University on a 12 h
light–dark cycle in a temperature- and humidity-controlled room (21–23 ◦ C and 40–60%,
respectively). They were fed on standard diet pellets for rodents (El Nasr, Egypt) and given
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water ad libitum. All animal handling steps were performed following the rules of the Ain
Shams University Faculty of Pharmacy Ethical Committee for the use of animal subjects
(No. 27, March 2020).
4.8.2. Induction of Tongue Ulcers
All rats were given pentobarbital intraperitoneal as anesthesia in a dose of 50 mg/kg.
Tongue ulcers were chemically induced in all rats except the control groups using cotton
swabs soaked in 20 µL of 50% acetic acid pressed onto the dorsal surface of the tongue for
1 min [72].
4.8.3. Treatment Preparation
The topical gel was formulated as 5% of CEAM, EFAM and BFAM dispersed in 0.5%
carboxymethyl cellulose. The extract and fractions were incorporated in the plain polymeric
gel base using geometric addition in order to ensure uniform drug distribution throughout
the base [72].
4.8.4. Experimental Design
The rats were randomly allocated into five groups (n = 18) and were given the following treatment for 14 days. Group 1 (Control): rats were treated with 1 drop of the respective
vehicle twice daily. Group 2 (Vehicle): rats underwent ulcer induction using acetic acid
and were given 1 drop of topical treatment containing vehicle only twice daily. Group 3
(CEAM): rats underwent ulcer induction using acetic acid and were treated with 1 drop
of a topical gel containing 5% CEAM twice daily. Group 4 (EFAM): rats underwent ulcer
induction using acetic acid and were treated with 1 drop of a topical gel containing 5%
EFAM twice daily. Group 5 (BFAM): rats underwent ulcer induction using acetic acid and
were treated with 1drop topical gel containing 5% BFAM twice daily. Rats were prohibited
from food and water for half an hour after each topical treatment application in order to
assure its adhesion on the rats’ tongues [7].
On days 3, 7, and 14, six rats from each group were sacrificed with an overdose of
pentobarbital. The tongues were dissected, weighed, and washed using ice-cold phosphate
buffered saline (PBS) (pH 7.2). Specimens were taken from the tongues and prepared for
biochemical, histopathological, and immunohistochemical analysis.
4.8.5. Biochemical Assessment of Inflammatory Markers
Tongue specimens were frozen, washed in ice-cold PBS (pH 7.2), and ground to obtain 20% homogenate using a tissue homogenizer (mini-BeadBeater-8, BioSpec products,
Bartlesville, OK, USA). Tissue fragments were then incubated in lysis buffer solution,
placed on ice, sonicated for 30 sec, and centrifuged at 4000 rpm for 15 min using a Sigma
2-7 Centrifuge (Osterode am Harz, Germany). Then, the supernatant was collected and
maintained at −80 ◦ C until performing the ELISA assay. The TNF-α and IL-2 levels in
tongue homogenates were measured using a commercial ready-made ELISA kit (Sigma
Aldrich Chemical Co., St Louis, MO, USA) according to the manufacturer’s instructions.
TNF-α and IL-2 contents were measured, presented as pg/mg protein. The protein concentration was determined using bovine serum albumin as the standard according to the
Lowry method [73].
4.8.6. Tongue Tissue Preparation for Staining
Specimens from the tongues were fixed in neutral buffered formalin (10%) for 72 h
for histopathological and immunohistochemical analysis. The fixed tongue tissues were
sequentially processed by alcohol and xylene and embedded in paraplast tissue-embedding
medium. A rotatory microtome was used to cut serial 4 µm tissue sections. Each section was
stained with Harris Hematoxylin and Eosin (H&E) as a conventional tissue examination
staining method according to [74].
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For the immunohistochemical staining, specimen paraffin blocks were cut by microtome at 4 µm thickness. The samples were deparaffinized and treated with 3% H2 O2 for
15 min. The slides were incubated with the primary antibody anti-PCNA (MA5-11358,
Thermo Fisher Scientific, Fremont, CA, USA) (1:100) for 1 h and washed using phosphate
buffered saline (PBS). The cells were incubated with HRP-conjugated secondary antibody
(EnVision-HRP kit, Agilent Dako, Santa Clara, CA, USA) for 20 min, rinsed with PBS, and
treated with DAB chromogen for 10 min, then rinsed with PBS. The slides were counterstained with Hematoxylin stain, dried, and cleared in xylene for microscopic examination
and quantification [75].
4.8.7. Histomorphometric Analysis
Six random non-overlapping fields per sample were selected for each positive antiPCNA section, and photomicrographs were captured at ×400 magnification.
Morphometric analysis was performed by calculating the mean area percentage
(mean%) of the brown-colored positively immunostained PCNA in the lingual covering mucosa, as per [76]. This was done by a specialist blinded to the experimental groups
using image analysis software (Image J, 1.41a, NIH, USA). All photomicrographs were
taken with a Leica Application Module linked to Full HD microscopic imaging equipment
(Leica Microsystems GmbH, Wetzlar, Germany).
4.9. Statistical Analysis
Results are reported as mean ± standard deviation (SD), and were analyzed via
one-way analysis of variance (ANOVA) followed by the Tukey–Kramer test for post hoc
analysis in order to compare between different groups at the same time interval, and via
two-way ANOVA followed by the Bonferroni post hoc test to compare between the groups
at different time intervals. The cell viability assay findings were examined using one-way
ANOVA followed by the Schiff multiple test. Statistical significance was defined as p < 0.05
probability values. All statistical analyses and graphs were performed and sketched using
GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla, CA, USA.
5. Conclusions
Alhagi maurorum ethyl acetate fraction, being a rich source of polyphenols, accelerated
the healing process in tongue ulcers owing to its high antioxidant capacity, as represented
by its potent free radical scavenging activity against DPPH, FRAP, its anti-inflammatory
activity via decreasing the mucosal content of the proinflammatory cytokines TNF-α and
IL-2, and its promotion of cell proliferation by increasing the expression of PCNA in
ulcerative lesions. These findings suggested that A. maurorum is a good candidate for oral
ulcer treatment, and warrants further clinical studies.
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